$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading Week 13/2015

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. in week 13/2015.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	8.67	2,131	18,469	33,294
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	10.40	203	2,111	0
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Option Exercise	M	0.00	1,622	0	4,868
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	277.70	843	234,102	19,293	20.1 K to 19.3 K (-4.19 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	281.15	1,000	281,150	20,136	21.1 K to 20.1 K (-4.73 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	272.69	282	76,897	21,136	21.4 K to 21.1 K (-1.32 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Sell	S	269.83	1,334	359,953	21,418	22.8 K to 21.4 K (-5.86 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	8.67	2,131	18,469	22,752	20.6 K to 22.8 K (+10.33 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	10.40	203	2,111	20,621	20.4 K to 20.6 K (+0.99 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Shapiro David	CMO and EVP - Devel ...	Buy	M	0.00	1,622	0	20,418	18.8 K to 20.4 K (+8.63 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Option Exercise	M	0.00	1,298	0	3,894
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	277.70	39	10,830	17,523	17.6 K to 17.5 K (-0.22 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Buy	M	0.00	1,298	0	17,562	16.3 K to 17.6 K (+7.98 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Option Exercise	M	0.00	649	0	1,947
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Adorini Luciano	Chief Scientific Of ...	Buy	M	0.00	649	0	10,060	9.4 K to 10.1 K (+6.90 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Option Exercise	M	0.00	4,868	0	14,603
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Sell	S	277.70	157	43,599	495,743	495.9 K to 495.7 K (-0.03 %)
Apr 03 2015	ICPT	INTERCEPT PHARMACE ...	Pruzanski Mark	CEO & President	Buy	M	0.00	4,868	0	495,900	491 K to 495.9 K (+0.99 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	293.34	300	88,001	16,264	16.6 K to 16.3 K (-1.81 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	292.16	100	29,216	16,564	16.7 K to 16.6 K (-0.60 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	291.00	100	29,100	16,664	16.8 K to 16.7 K (-0.60 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	289.00	100	28,900	16,764	16.9 K to 16.8 K (-0.59 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	288.00	100	28,800	16,864	17 K to 16.9 K (-0.59 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	287.00	100	28,700	16,964	17.1 K to 17 K (-0.59 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	286.00	100	28,600	17,064	17.2 K to 17.1 K (-0.58 %)
Apr 01 2015	ICPT	INTERCEPT PHARMACE ...	Duncan Barbara Gayle	Chief Financial Off ...	Sell	S	285.00	100	28,500	17,164	17.3 K to 17.2 K (-0.58 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	294.82	90	26,534	1,120,324	1.1 M to 1.1 M (-0.01 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	293.85	2,500	734,625	1,120,414	1.1 M to 1.1 M (-0.22 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	292.13	6,000	1,752,780	1,122,914	1.1 M to 1.1 M (-0.53 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	291.12	3,700	1,077,144	1,128,914	1.1 M to 1.1 M (-0.33 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	290.02	13,974	4,052,739	1,132,614	1.1 M to 1.1 M (-1.22 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	289.07	15,131	4,373,918	1,146,588	1.2 M to 1.1 M (-1.30 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	288.11	26,028	7,498,927	1,161,719	1.2 M to 1.2 M (-2.19 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	287.16	18,041	5,180,654	1,187,747	1.2 M to 1.2 M (-1.50 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	286.24	7,611	2,178,573	1,205,788	1.2 M to 1.2 M (-0.63 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	285.18	23,903	6,816,658	1,213,399	1.2 M to 1.2 M (-1.93 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	284.20	16,845	4,787,349	1,237,302	1.3 M to 1.2 M (-1.34 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	282.87	9,357	2,646,815	1,254,147	1.3 M to 1.3 M (-0.74 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	282.13	8,397	2,369,046	1,263,504	1.3 M to 1.3 M (-0.66 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	SILVERSTEIN JONATHAN	Director	Sell	S	281.11	5,623	1,580,682	1,271,901	1.3 M to 1.3 M (-0.44 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	294.82	90	26,534	1,120,324	1.1 M to 1.1 M (-0.01 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	293.85	2,500	734,625	1,120,414	1.1 M to 1.1 M (-0.22 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	292.13	6,000	1,752,780	1,122,914	1.1 M to 1.1 M (-0.53 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	291.12	3,700	1,077,144	1,128,914	1.1 M to 1.1 M (-0.33 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	290.02	13,974	4,052,739	1,132,614	1.1 M to 1.1 M (-1.22 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	289.07	15,131	4,373,918	1,146,588	1.2 M to 1.1 M (-1.30 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	288.11	26,028	7,498,927	1,161,719	1.2 M to 1.2 M (-2.19 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	287.16	18,041	5,180,654	1,187,747	1.2 M to 1.2 M (-1.50 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	286.24	7,611	2,178,573	1,205,788	1.2 M to 1.2 M (-0.63 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	285.18	23,903	6,816,658	1,213,399	1.2 M to 1.2 M (-1.93 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	284.20	16,845	4,787,349	1,237,302	1.3 M to 1.2 M (-1.34 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	282.87	9,357	2,646,815	1,254,147	1.3 M to 1.3 M (-0.74 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	282.13	8,397	2,369,046	1,263,504	1.3 M to 1.3 M (-0.66 %)
Mar 30 2015	ICPT	INTERCEPT PHARMACE ...	ORBIMED ADVISORS LLC	Director	Sell	S	281.11	5,623	1,580,682	1,271,901	1.3 M to 1.3 M (-0.44 %)